218 related articles for article (PubMed ID: 16640573)
21. Bactericidal and inhibitory effects of azole antifungal compounds on Mycobacterium smegmatis.
Jackson CJ; Lamb DC; Kelly DE; Kelly SL
FEMS Microbiol Lett; 2000 Nov; 192(2):159-62. PubMed ID: 11064188
[TBL] [Abstract][Full Text] [Related]
22. Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model.
Rubakova E; Petrovskaya S; Pichugin A; Khlebnikov V; McMurray D; Kondratieva E; Baturina I; Kondratieva T; Apt A
Tuberculosis (Edinb); 2007 Mar; 87(2):134-44. PubMed ID: 17011827
[TBL] [Abstract][Full Text] [Related]
23. Altered expression profile of mycobacterial surface glycopeptidolipids following treatment with the antifungal azole inhibitors econazole and clotrimazole.
Burguière A; Hitchen PG; Dover LG; Dell A; Besra GS
Microbiology (Reading); 2005 Jun; 151(Pt 6):2087-2095. PubMed ID: 15942015
[TBL] [Abstract][Full Text] [Related]
24. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
[TBL] [Abstract][Full Text] [Related]
25. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
26. In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates.
Imperiale BR; Cataldi ÁA; Morcillo NS
Rev Argent Microbiol; 2017; 49(4):332-338. PubMed ID: 28919150
[TBL] [Abstract][Full Text] [Related]
27. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
Byrne ST; Denkin SM; Zhang Y
J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
[TBL] [Abstract][Full Text] [Related]
28. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
[TBL] [Abstract][Full Text] [Related]
29. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.
Sriram D; Yogeeswari P; Yelamanchili Priya D
Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086
[TBL] [Abstract][Full Text] [Related]
30. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
31. Latent tuberculosis: models, mechanisms, and novel prospects for eradication.
Riska PF; Carleton S
Semin Pediatr Infect Dis; 2002 Oct; 13(4):263-72. PubMed ID: 12491232
[TBL] [Abstract][Full Text] [Related]
32. A comparison of conventional and radiometric methods for the assessment of anti-tubercular activity of drugs against Mycobacterium tuberculosis in mice and macrophage models.
Jhamb SS; Singh RP; Singh PP
Indian J Tuberc; 2008 Apr; 55(2):70-6. PubMed ID: 18516822
[TBL] [Abstract][Full Text] [Related]
33. Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis.
El-Ridy MS; Mostafa DM; Shehab A; Nasr EA; Abd El-Alim S
Int J Pharm; 2007 Feb; 330(1-2):82-8. PubMed ID: 17049192
[TBL] [Abstract][Full Text] [Related]
34. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
Khan A; Sarkar S; Sarkar D
Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
[TBL] [Abstract][Full Text] [Related]
35. Antituberculosis activity of certain antifungal and antihelmintic drugs.
Sun Z; Zhang Y
Tuber Lung Dis; 1999; 79(5):319-20. PubMed ID: 10707260
[TBL] [Abstract][Full Text] [Related]
36. Short report: modulation of Mycobacterium tuberculosis infection by Plasmodium in the murine model.
Scott CP; Kumar N; Bishai WR; Manabe YC
Am J Trop Med Hyg; 2004 Feb; 70(2):144-8. PubMed ID: 14993625
[TBL] [Abstract][Full Text] [Related]
37. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
Dinakaran M; Senthilkumar P; Yogeeswari P; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):11-8. PubMed ID: 18078735
[TBL] [Abstract][Full Text] [Related]
38. Antimycobacterial activities of novel fluoroquinolones.
Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
[TBL] [Abstract][Full Text] [Related]
39. [The virulence of resistance strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. II. Experimental therapeutic effect on guinea pigs infected by resistant strains of Mycobacterium tuberculosis].
Yan BS
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):206-8. PubMed ID: 6816558
[No Abstract] [Full Text] [Related]
40. [Comparison of in-vitro and in-vivo activities of enoxacin and ofloxacin against the Mycobacterium tuberculosis].
Xu G; Li H; Liu S
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Jun; 18(3):175-7, 192. PubMed ID: 8565090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
